| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 08/23/2006 | CN1270711C Aminochlorodipin, irbesartan compound preparation |
| 08/23/2006 | CN1270710C Medicinal solution for treating ulceration and inflammation |
| 08/23/2006 | CN1270709C Tiotropium aerosol inhalant and its preparation method |
| 08/23/2006 | CN1270708C Medicinal composition for treating interstitial cystitis |
| 08/23/2006 | CN1270707C Ophthalmic solution |
| 08/23/2006 | CN1270706C Coating agent for reducing high blood pressure and its use |
| 08/23/2006 | CN1270705C External essence oil for treating beriberi |
| 08/23/2006 | CN1270704C Application of combination of L-lysine, dimethylamino tetracycline hydrochloride and metronidazole |
| 08/23/2006 | CN1270703C Sustained release preparation of phenoprolamine hydrochloride and its preparing process |
| 08/23/2006 | CN1270702C Intravenous injection liquid of coenzyme Q10, and its prepn. method |
| 08/23/2006 | CN1270701C Dexamethasone acetate plaster and its prepn. |
| 08/23/2006 | CN1270691C Salicylic acid solution and its preparation method |
| 08/22/2006 | USRE39245 Galactopyranosides and their use |
| 08/22/2006 | US7094930 Pharmaceutically acceptable salts of sertraline and pharmaceutical compositions thereof |
| 08/22/2006 | US7094928 reacting 1-(2,5-dimethoxyphenyl)-2-bromoethanone with hexamine, then acylating with haloacetylchloride and sodium acetate, selectively reducing with sodium borohydride and stannous chloride, and quaternization, to form midodrine hydrochloride, used as hypertensive agents |
| 08/22/2006 | US7094916 vitamin D3 derivative as anti-cancer agent, for the treatment of skin diseases such as psoriasis as well as skin conditions such as wrinkles, slack skin, dry skin and insufficient sebum secretion, for immune disorders, metabolic bone diseases and also used as antiinflammatory agent |
| 08/22/2006 | US7094911 Biphenyl and biphenyl-analogous compounds as integrin antagonists |
| 08/22/2006 | US7094909 Reacting an amide compound containing hydroxy and a carboxyl group and having benzene ring, with a halogenated alkyl aminocarbonyl-pyrrolidine with 2-fluoro groups substituted at the ring carbon, by amindation of amine and carboxyl group |
| 08/22/2006 | US7094903 Processes for the preparation of substituted isoxazoles and 2-isoxazolines |
| 08/22/2006 | US7094900 N-Aryl-2-oxazolidinones and their derivatives |
| 08/22/2006 | US7094899 Vitreous form of known bradykinin antagonist |
| 08/22/2006 | US7094896 Diaminothiazoles having antiproliferative activity |
| 08/22/2006 | US7094895 Inotropic agents such as (S)-N-tert-butyloxycarbonyl-N-methyl-tyrosyl)-4-(4-nitrophenyl)-piperazine, used for preventing and/or prophylaxis of diseases associated with adenosine 5'-triphosphate |
| 08/22/2006 | US7094887 UDP-N-acetylglucosamine: galactose-β1,3-N-acetylgalactosamine-α-R(GlcNAc to GalNAc) β1,6-N-acetylglucosaminyltransferase, C2GnT3 |
| 08/22/2006 | US7094877 Protein for use in treatment of inflammation, nervous system, pain, arthritic and skin disorders |
| 08/22/2006 | US7094831 Polymerization of vinyl acetate polymer in presenc eof free radical catalyst |
| 08/22/2006 | US7094810 pH-sensitive block copolymers for pharmaceutical compositions |
| 08/22/2006 | US7094809 Topical administration of dihydroxytoluene to block viral replication |
| 08/22/2006 | US7094808 Antineoplastic polyamines capable of uptake by a target cell upon administration to a human or non-human animal, and upon uptake bind via an electrostatic interaction between positively charged nitrogen and biological counter- anions |
| 08/22/2006 | US7094807 Viricides; hepatitis virus |
| 08/22/2006 | US7094806 Bactericides, bacteriostats |
| 08/22/2006 | US7094805 Total synthesis of merrilactone A |
| 08/22/2006 | US7094804 Water free ubiquinone concentrate |
| 08/22/2006 | US7094803 Biologically active raspailamide compounds |
| 08/22/2006 | US7094802 PKB-3564 substance with neovascularization inhibitory activity |
| 08/22/2006 | US7094801 Inhibiting the expression of VCAM-1; treating inflammatory disorders including rheumatoid arthritis, atherosclerosis, COPD, asthma, allergic rhinitis and restinosis |
| 08/22/2006 | US7094800 pyrrolizinones, e.g., (3S,6R,7aS)-6-amino-5-oxo-hexahydro-pyrrolizine-3-carbonitrile trifluoroacetate, used for reducing blood sugar, treating type 2 diabetes, and treating insulin resistance |
| 08/22/2006 | US7094799 A single, thermodynamical stable crystal structure, is crystallized from a cooled and agitated solvent solution, analgesic drug for reducing pain |
| 08/22/2006 | US7094798 pyrrolocarbazole derivatives, e.g., 2-(4-(2,6-Dichlorophenyl)-9-hydroxy-1,3-dioxo-2,3-dihydropyrrolo[3,4-c]carbazol-6 (1H)-yl)ethyl methanesulfonate |
| 08/22/2006 | US7094797 Organ fibrosis inhibitor |
| 08/22/2006 | US7094796 Coupling product between tryptamine and an alpha-amino acid, process for its preparation as well as its application in the neurocosmetic field |
| 08/22/2006 | US7094795 by alkylation of one of the OH groups, stereoselective enzymatic ester formation or ester hydrolysis, and hydrolysis; and alkylation of the other OH group with a 2-phenyl- or heteroaryloxazolylalkyl halide, sulfonate or triflate |
| 08/22/2006 | US7094794 used for lowering the blood glucose and for the prevention and treatment of diabetes |
| 08/22/2006 | US7094792 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
| 08/22/2006 | US7094791 Derivatives of 3-hydroxy-pyrrole-2,4-dicarboxylic acid and uses thereof |
| 08/22/2006 | US7094790 containing a pyrrole ring, e.g., 4-{2-[2-(2-(R)-Methyl-pyrrolidin-1-yl)-ethyl]-benzothiazol-5-yl}-benzonitrile; useful for treating conditions and disorders related to memory and cognition processes, neurological processes, cardiovascular function, and body weight. |
| 08/22/2006 | US7094789 5-substituted isoquinoline derivatives |
| 08/22/2006 | US7094788 A tropane ester derivative for treating asthma, chronic obstractive pulmonary disease, vagally induced sinus bradycardia, heart rhythm disorders, spasms in the gastrointestinal or urinary tracts, and menstrual pain |
| 08/22/2006 | US7094787 Compositions for regulating desire for smoking |
| 08/22/2006 | US7094786 Method of treating nausea, vomiting, retching or any combination thereof |
| 08/22/2006 | US7094785 administering Imatinib or a salt, especially the mesylate; reduced the need for a phlebotomy. |
| 08/22/2006 | US7094784 High affinity ligands for nociceptin receptor ORL-1 |
| 08/22/2006 | US7094783 Inhibitors of serine proteases; for therapy of thromboembolic disorder |
| 08/22/2006 | US7094782 Administering pyrazolono[1,5a]-1,3,5-triazines that are alkynyl-, cyano- and 2,3-dihydrobenzofuranyl-substituted for treating supranuclear palsy |
| 08/22/2006 | US7094781 Sulfamides and their use as endothelin receptor antagonists |
| 08/22/2006 | US7094780 3-aminoquinazolin-2,4-dione antibacterial agents |
| 08/22/2006 | US7094779 2-(3-indolylmethyl)-1-benzoyl-4-oxime-piperazine derivatives, e.g., 1-{(2R)-1-[3,5-bis(trifluoromethyl)benzoyl]-2-(1H-indol-3-ylmethyl)-piperazin-4-yl}-2-propanone O-[2-(dimethylamino)-ethyl]oxime, used for treatment of CNS disorders. |
| 08/22/2006 | US7094778 Nervous system disorders; muscular disorders; urogenital disorders; gastrointestinal disorders; repiratory system disorders; antiallergens; side effect reduction |
| 08/22/2006 | US7094777 5-HT2A receptor ligands |
| 08/22/2006 | US7094776 cyclohexane ring is 3,5-dihydroxy-substituted and 2,4-alkylene-bridged; treating metabolic bone disease including senile, postmenopausal, and steroid-induced osteoporosis, osteomalacia, renal osteodystrophy and rickets |
| 08/22/2006 | US7094775 Method of treating breast cancer using a combination of vitamin D analogues and other agents |
| 08/22/2006 | US7094774 26,27-homologated-20-epi-2-alkylidene-19-nor-vitamin D compounds |
| 08/22/2006 | US7094773 LTA4 hydrolase inhibitors |
| 08/22/2006 | US7094772 Phosphonate compounds |
| 08/22/2006 | US7094771 Especially for treating cancer |
| 08/22/2006 | US7094770 Treating hepatitus B, C and D; AIDS; antiproliferative agents |
| 08/22/2006 | US7094769 2-aminocarbonyl-9H-purine derivatives |
| 08/22/2006 | US7094768 Nucleoside derivatives for treating hepatitis C virus infection |
| 08/22/2006 | US7094766 administering a DNA oligonucleotide that is 2 200 nucleotides in length and comprises a phosphodiester backbone for reducing photoaging and for treatment and prevention of hyperproliferative diseases, especially skin cancer |
| 08/22/2006 | US7094765 Antisense restenosis composition and method |
| 08/22/2006 | US7094764 Substituted benzimidazole-, Benztriazole-, and benzimidazolone-O-glucosides |
| 08/22/2006 | US7094763 e.g., 2-(4-Ethylbenzyl)-4-( beta -D-glucopyranosyl)-1H-indole, used for the treatment or prophylaxis of diabetes and Syndrome X. |
| 08/22/2006 | US7094762 Use of ribose to treat fibromyalgia |
| 08/22/2006 | US7094583 mixtures of dextrins and sugars used for enhanced delivery of eucaryotic expression vectors, to cells in vivo; gene therapy |
| 08/22/2006 | US7094556 Diagnosis and treatment of malignant neoplasms |
| 08/22/2006 | US7094550 Diagnosing atherosclerosis in humans; obtain blood, incubate with confining complex, detect signal from bound complex, evaluate for atherosclerosis |
| 08/22/2006 | US7094546 screening gene expression inhibition via incubating mrna, determining expression in presence of test compound, then comparing levels; gene knockout |
| 08/22/2006 | US7094431 Method of healing skin wounds in mammals and a composition therefor |
| 08/22/2006 | US7094429 in-situ conversion and incorporation of tannate salt complexes of antihistamine, antitussive, decongestant and anticholinergic class of pharmaceutical compounds into a sustained release therapeutic liquid or semi-solid dosage form |
| 08/22/2006 | US7094427 Combination immediate release controlled release levodopa/carbidopa dosage forms |
| 08/22/2006 | US7094426 a core granule or tablet, an acid-unstable benzimidazole drug, and an excipient in a gelatin capsule covered with an enteric coating; controlled release in the intestines, rather than the stomach |
| 08/22/2006 | US7094424 Cationic lipid compositions targeting angiogenic endothelial cells |
| 08/22/2006 | US7094422 With dermal penetration enhancer, octyl salicylate |
| 08/22/2006 | US7094421 Plaster containing 4-biphenylacetic acid |
| 08/22/2006 | US7094416 two-phase hardenable cosmetic mask to be mixed and then spread with a spatula; improved organoleptic properties |
| 08/22/2006 | US7094414 Famotidine injections |
| 08/22/2006 | US7094411 Avirulent, immunogenic flavivirus chimeras |
| 08/22/2006 | US7094397 Methods and reagents for the treatment of multiple sclerosis |
| 08/22/2006 | US7094392 Heating antihistamine drug vaporize; cooling to form a condensation aerosol; kit for dispensing thin coating |
| 08/22/2006 | US7094391 oral Lime disease vaccination using pure Outer surface protein A specific serum Immunoglobulin A antibodies; immunotherapy |
| 08/22/2006 | US7093684 Mounting configuration and method for a motorcycle seat |
| 08/22/2006 | CA2328085C Solid dispersion containing sialic acid derivative |
| 08/22/2006 | CA2299503C Anti-first-pass effect compounds |
| 08/22/2006 | CA2279967C Method of enhancing hair growth |
| 08/22/2006 | CA2270301C Hydroxyindoles, their use as inhibitors of phosphodiesterase 4, and processes for their preparation |
| 08/22/2006 | CA2267109C Use of conjugated linoleic acid to enhance natural killer lymphocyte function |
| 08/22/2006 | CA2265780C Sulfated polysaccharides and uses thereof in medical treatment |
| 08/22/2006 | CA2242102C Quinazoline derivatives as antitumor agents |
| 08/22/2006 | CA2240927C Process for production of piperidine derivatives |
| 08/22/2006 | CA2214979C Improvements in or relating to organic compositions |